1-3 of 3
Lisa Hamilton, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Observational Study of Anaemia Management in Patients with NHL Receiving CHOP-14 or -21 (With or Without Rituximab)

Gregor Verhoef, MD, Hans E Johnsen, MD, Francesca Gaia Rossi, MD, Antonio Salar, MD, PhD, Lisa Hamilton, MSc, W. Marieke Schoonen, PhD, Beatriz Pujol, PhD, Ulrich Duhrsen, MD
Journal: Blood
Blood (2008) 112 (11): 4948.
https://doi.org/10.1182/blood.V112.11.4948.4948
Published: 2008
Journal Articles

Darbepoetin alfa Administered Every 3 Weeks Is Effective in Correcting Hemoglobin and Reducing Transfusion Requirements in Anemic Patients with Hematological Malignancies Receiving Chemotherapy: A Retrospective Observational Study Reflecting Real-World Clinical Practice in Europe.

Bertrand Coiffier, MD, David Coeffic, MD, Frank Strohbach, MD, Marcus Schweigert, MD, Hirsh Koyi, MD, PhD, Lisa Hamilton, MSc, Tamás Suto, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4085.
https://doi.org/10.1182/blood.V110.11.4085.4085
Published: 2007
Journal Articles

Risk of Adverse Events Is Similar in Patients (Pts) Who Did or Did Not Achieve Hemoglobin (Hb) Above 12g/dL in a Phase 3 Clinical Trial of Darbepoetin alfa (DA) Administered Weekly (QW) or Every 3 Weeks (Q3W) in Anemic Cancer Pts Receiving Chemotherapy.

Heinz Ludwig, MD, Jean-Luc Canon, MD, Johan Vansteenkiste, MD, PhD, Lisa Hamilton, MSc, Tamás Suto, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 4086.
https://doi.org/10.1182/blood.V110.11.4086.4086
Published: 2007